Advances in novel anti-HBV agents acting on different targetsXU Zhi-hui, LIU Yan, XU Dong-ping257-261,283
Combination therapy with interferons and nucleos(t)ide analogues creating a new way of HBsAg clearanceCHEN Xin-yue, LIU Ya-li262-265
Current status and prospect of diagnosis and treatment of inherited metabolic liver disease in childrenZHU Shi-shu, ZHANG Hong-fei270-272
Combination therapy in HBeAg-positive chronic hepatitis B patients with poor virological response/HBV resistance to NAsJIN Yi, HUANG Chun-yang, WEI Fei-li, HE Zhi-min, ZHENG Yan-hong, MA Li-na, CHEN Xin-yue273-278
Efficacy and safety of interferon combined with lamivudine in treatment of cirrhotic children with HBeAg-positive compensated hepatitis B董漪, 张鸿飞, 徐志强, 陈大为, 甘雨, 王丽旻, 王福川, 闫建国, 张敏279-283
Preliminary clinical observation of direct-acting antiviral agents in patients with HCV-related liver cirrhosis and HCV recurrence after liver transplantation张敏, 苏海滨, 周双男, 周霞, 贺希, 张达利, 汤汝佳, 刘振文284-287
Risk factors for infections in patients with acute-on-chronic liver failure and their influences on short-term outcome臧红, 刘鸿凌, 郝玉清, 温斌, 朱冰, 刘婉姝, 辛绍杰, 游绍莉288-292
Clinical study of transjugular intrahepatic porto-systemic shunt combined with esophageal varices embolization郐涛, 刘福全, 岳振东, 赵洪伟, 王磊, 范振华, 赵孟菲, 何福亮, 于海洋293-296
Application of early restrictive fluid resuscitation combined with painless gastroscope in the treatment of massive upper gastrointestinal bleeding in liver cirrhotic patientsWANG Xiao-mei, ZHAO Rui, WU Yun-hai, ZHANG Ming-xiang, ZHANG Li-yao, SUN Li, MU Feng297-300